WA, ID, TX, NY, AZ, & OR

Placenta Derived Amniotic Stem Cells in Spokane, WA & Coeur d’Alene, ID

Stem cell therapy, a cornerstone of regenerative medicine, harnesses the power of stem cells to replace or regenerate human cells, tissues, or organs, restoring normal function. These cells, especially those derived from placental tissues, are unique in their ability to differentiate into various cell types, offering a versatile solution to a myriad of medical conditions. Placental tissues, including the amnion, umbilical cord, and chorion, are rich sources of mesenchymal stem cells (MSCs) and other biologics. These MSCs, combined with growth factors, cytokines, and the extracellular matrix, have shown promise in treating conditions ranging from neurological disorders and orthopedic injuries to diabetes and heart diseases. The therapeutic potential of these cells lies not only in their healing capabilities but also in their anti-inflammatory and immunomodulatory effects, making treatments both effective and safe. If you’re seeking a non-surgical, cutting-edge solution to chronic conditions, stem cell therapy might be the answer. Ready to explore the potential of placenta-derived stem cells in Spokane, WA or Coeur d’Alene, ID? Book your appointment online today with Complete Medical Weight Loss and Anti-Aging Clinic!

Benefits of Stem Cell Therapy:

  • Natural and non-surgical treatment option.
  • Potential to regenerate damaged tissues and organs.
  • Anti-inflammatory and immunomodulatory effects.
  • Treatment for a wide range of conditions, from orthopedic injuries to neurological disorders.
  • Minimal ethical concerns with placental-derived stem cells.
  • Reduced recovery time compared to traditional surgeries.
  • Preservation of tissue homeostasis, growth, and repair.
  • Enhanced quality of life and potential for long-term relief.

FAQs

Purified Amniotic Fluid consists of tiny, membrane-bound extracellular vesicles (EVs) released by the developing fetus, placenta, and mother into the amniotic fluid. Essentially, it represents the nurturing fluid of new life.

These extracellular vesicles are carefully harvested from the amniotic fluid during a full-term, healthy Caesarean birth. Typically, a nominal volume of amniotic fluid is extracted and assessed for any diseases. The production of Purified Amniotic Fluid adheres to a specialized process, aligning with the standards set by the American Association of Tissue Banks (AATB) and in compliance with FDA guidelines. Every donor undergoes a meticulous screening process, provides consent, and the extracted fluid is then tested for sterility by an independent, third-party laboratory.

A single 1 cc vial of Purified Amniotic Fluid contains an average of approximately 250 billion particles, with a variance of +/- 100 billion particles.

Wharton’s Jelly is a gel-like substance found in the umbilical cord, playing a pivotal role in offering structural support and delivering essential growth factors and extracellular vesicles vital for the health of both the fetus and mother. Leveraging advanced proprietary techniques, Neobiosis’ team of experts extracts the acellular matrix from Wharton’s Jelly obtained from fresh, healthy donor umbilical cords. This process ensures the preservation of the biological activity of soluble growth factors, EV components, and structural matrix elements.

The Wharton’s Jelly Matrix is derived from the umbilical cords of healthy, consenting mothers. The collection process is overseen by our exclusive birth tissue collection partner, accredited by AATB. This procedure strictly adheres to the guidelines set by the FDA and CDC. Every tissue used in clinical applications undergoes rigorous screening and clearance processes before being deemed fit for research and clinical trials.

Wharton’s Jelly Matrix is integral for tissue equilibrium, growth, and repair. It’s a rich source of growth factors, extracellular vesicles, and structural matrix components, all of which play a crucial role in regenerative medicine and various therapeutic applications.

The sourcing and production of Wharton’s Jelly Matrix prioritize safety and quality. All clinical-grade tissues are not only consented and screened but also cleared after rigorous testing by a third-party, CLIA-certified laboratory.

Yes, Neobiosis employs a unique proprietary technology to extract the acellular matrix from Wharton’s Jelly. This technology ensures that the biological activity of the matrix’s components remains intact, providing maximum therapeutic benefits.

ANY QUERIES
Don't wait to
improve your life!
Call Now Button